Our client’s scientific focus has resulted in 19 marketed products that are benefiting hundreds of thousands of people, a pipeline of late-stage drug candidates and unmatched patient access programs to ensure medications are available to those who could not otherwise afford them.
Today, the research and development effort is the largest it has ever been and includes approximately 200 clinical studies evaluating compounds with the potential to become the next generation of innovative therapies for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions.
Signature’s Consultants needed to be well-versed in 6 major sectors with the ability to create detail-level deliverables based on previous experience and knowledge.
The research-based company relied on Signature Consultants to work both internally and externally to meet their objectives.
Signature’s team of network engineers, storage specialists, system administrators, project managers, quality assurance, and change management professionals integrated cohesively with one another and the client’s existing teams to bring the project to a successful launch.
One and a half years into the project, the client continues to engage Signature’s resource team and the project continues to grow, aiding in the completion of this highly visible project throughout the organization.
The results have been exceptional as Signature
continues to work closely with the client and the changing aspects of the project, its time frame and budgets.
The client has a strong team within its organization that can be leveraged.
The response exceeded the expectations of the client and has resulted in a collaborative working relationship with the biopharmaceutical company.
